First Round: Assort Health: $26 Million Secured For Specialty-Specific GenAI Platform For Managing Patient Phone Calls

Assort Health, which is a specialty-specific AI platform for managing patient phone calls, announced a new round of institutional financing co-led by First Round Capital and Chemistry, with participation from existing investor Quiet Capital. This funding Assort Health's total capital raised to $26 million. These investors join Assort Health's existing backers, Four Acres, Tau Ventures, and several notable angel investors, including senior executives and founders from Athena Health, Astrana Health, Flatiron Health, Infinitus, Mammoth Biosciences, Mercury, PathAI, and Presto. The post Assort Health: $26 Million Secured For Specialty-Specific GenAI Platform For Managing Patient Phone Calls appeared first on Pulse 2.0.